These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35230655)

  • 21. Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations.
    Almeida LT; Gonçalves AB; Franco-Luiz APM; Silva TBS; Alves PA; Monte-Neto RLD
    Mem Inst Oswaldo Cruz; 2022; 117():e220050. PubMed ID: 35766650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants.
    Nörz D; Grunwald M; Tang HT; Weinschenk C; Günther T; Robitaille A; Giersch K; Fischer N; Grundhoff A; Aepfelbacher M; Pfefferle S; Lütgehetmann M
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater.
    Wilhelm A; Agrawal S; Schoth J; Meinert-Berning C; Bastian D; Orschler L; Ciesek S; Teichgräber B; Wintgens T; Lackner S; Weber FA; Widera M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern.
    Pinkhover NP; Pontbriand KM; Fletcher KP; Sanchez E; Okello K; Garvey LM; Pum A; Li K; DeOliveira G; Proctor T; Feenstra JDM; Sorel O; Gandhi M; Auclair JR
    Microbiol Spectr; 2024 Feb; 12(2):e0348423. PubMed ID: 38206048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of SARS-CoV-2 Variants Using RT-qPCRs by Targeting Recurrent Mutation Sites: A Diagnostic Laboratory Experience from Multi-Center Regional Study, August 2020-December 2021, Poland.
    Wegrzynska K; Komiazyk M; Walory J; Kozinska A; Wasko I; Baraniak A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Application of Real-Time PCR-Based Screening for Identification of Omicron SARS-CoV-2 Variant Sublineages.
    Esman A; Dubodelov D; Khafizov K; Kotov I; Roev G; Golubeva A; Gasanov G; Korabelnikova M; Turashev A; Cherkashin E; Mironov K; Cherkashina A; Akimkin V
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing.
    Nasereddin A; Golan Berman H; Wolf DG; Oiknine-Djian E; Adar S
    Microbiol Spectr; 2022 Aug; 10(4):e0073622. PubMed ID: 35758686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster - Nebraska, November-December 2021.
    Jansen L; Tegomoh B; Lange K; Showalter K; Figliomeni J; Abdalhamid B; Iwen PC; Fauver J; Buss B; Donahue M
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1782-1784. PubMed ID: 34968376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
    Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
    Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex.
    Robles-Escajeda E; Mohl JE; Contreras L; Betancourt AP; Mancera BM; Kirken RA; Rodriguez G
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants.
    Dächert C; Muenchhoff M; Graf A; Autenrieth H; Bender S; Mairhofer H; Wratil PR; Thieme S; Krebs S; Grzimek-Koschewa N; Blum H; Keppler OT
    Med Microbiol Immunol; 2022 Feb; 211(1):71-77. PubMed ID: 35061086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2.
    Shipulin GA; Savochkina Y; Shuryaeva AK; Glushchenko EE; Luparev AR; Polyakova VA; Danilov DI; Davydova EE; Vinogradov KS; Stetsenko IF; Aiginin AA; Matsvay AD; Kolbutova KB; Bogdan SA; Vashukova MA; Yudin SM
    Heliyon; 2023 Jun; 9(6):e16917. PubMed ID: 37287602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of saliva and RT-PCR screening for SARS-CoV-2 variants of concern: Surveillance and monitoring.
    Zerbinati RM; Palmieri M; Schwab G; Felix AC; Martinho H; Giannecchini S; To KK; Lindoso JAL; Romano CM; Braz-Silva PH
    J Med Virol; 2022 Sep; 94(9):4518-4521. PubMed ID: 35524465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
    J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.
    Pérez-Santosa L; Kourí-Cardellá V; Tejero-Suárez Y; Macías-Roig LM; Pintos-Saavedra Y; Medero-Díaz D; Figueredo-Amador C; Naranjo-González C; Morales-Arredondo D; Tamayo-Pérez NE; Martínez-Montesino Y; López-Almaguer Y; de Armas-Fernández JR; Portal-Miranda JA; Guzmán-Tirado MG
    MEDICC Rev; 2022 Oct; 24(3-4):18-23. PubMed ID: 36417330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.